JP Morgan Chase’s Athenahealth, Inc. ATHN Stock Holding History

JP Morgan Chase’s Portfolio ATHN Stock Details ATHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-40,000	Closed	-$5.34M	–	6085
2018 Q3	$5.34M	Sell	40,000 -6,000	-13%	-$899K	﹤0.01%	2688
2018 Q2	$7.32M	Buy	+46,000	New	+$6.82M	﹤0.01%	2390
2018 Q1	–	Sell	-45,000	Closed	-$5.99M	–	5760
2017 Q4	$5.99M	Hold	45,000	–	–	﹤0.01%	2538
2017 Q3	$5.57M	Hold	45,000	–	–	﹤0.01%	2492
2017 Q2	$6.33M	Hold	45,000	–	–	﹤0.01%	2317
2017 Q1	$5.07M	Sell	45,000 -3,000	-6%	-$350K	﹤0.01%	2416
2016 Q4	$5.05M	Buy	+48,000	New	+$5.16M	﹤0.01%	2453
2016 Q1	–	Sell	-35,000	Closed	-$5.63M	–	5090
2015 Q4	$5.63M	Buy	+35,000	New	+$5.41M	﹤0.01%	2148

JP Morgan Chase's ATHN Position: Q1 2019 in Review

JP Morgan Chase sold out of Athenahealth, Inc. (ATHN) in Q1 2019, closing a stake of 251,393 shares — an estimated $33.2M sold.

JP Morgan Chase first reported a position in ATHN in Q2 2013 and held it in 23 quarters. The position peaked at $85.7M in Q1 2014. 0 funds tracked by Wall St. Rank hold ATHN as of Q1 2019.

JP Morgan Chase reported no remaining Athenahealth, Inc. position as of Q1 2019 after selling out during the quarter.
JP Morgan Chase sold 251,393 Athenahealth, Inc. shares in Q1 2019, an estimated $33.2M.
JP Morgan Chase first reported a position in Athenahealth, Inc. in Q2 2013 and held it in 23 quarters.
JP Morgan Chase's Athenahealth, Inc. position peaked at $85.7M in Q1 2014.
0 funds tracked by Wall St. Rank held Athenahealth, Inc. as of Q1 2019.

Based on JP Morgan Chase's 13F filing for Q1 2019, filed 7 May 2019.